Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology changes appears above the page, and the site revision updates from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:09:58.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:27:06.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Access to the study record returns a 403 Forbidden page instead of the study details, preventing viewing the trial information. The page displays a 403 message with a Home button, indicating restricted access to the content.
    Difference
    20%
    Check dated 2026-09-23T00:18:51.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 appears and the older revision tag v3.6.6 is removed, along with removal of the Prostate cancer and related topics: MedlinePlus Genetics entries. This update reflects metadata changes to page versioning and topic tagging rather than substantive study information.
    Difference
    0.2%
    Check dated 2026-09-16T00:09:16.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added related topics entries for Prostate cancer and MedlinePlus Genetics to the study page, expanding background context and links to external resources.
    Difference
    0.2%
    Check dated 2026-09-08T22:43:18.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.6.6, replacing the previous revision text, indicating a site version update. The related topics section has been reduced by removing Prostate cancer and MedlinePlus Genetics, affecting only ancillary metadata rather than the study content.
    Difference
    0.2%
    Check dated 2026-09-01T19:29:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.